BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ouranidis A, Vavilis T, Mandala E, Davidopoulou C, Stamoula E, Markopoulou CK, Karagianni A, Kachrimanis K. mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 2022;10:50. [DOI: 10.3390/biomedicines10010050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Vavilis T, Stamoula E, Sachinidis A, Lamprinou M, Dardalas I, Papazisis G. Biopharmaceuticals against substance use disorders - Present and future. Eur J Pharmacol 2023;944:175587. [PMID: 36775113 DOI: 10.1016/j.ejphar.2023.175587] [Reference Citation Analysis]
2 Kafetzis KN, Papalamprou N, McNulty E, Thong KX, Sato Y, Mironov A, Purohit A, Welsby PJ, Harashima H, Yu-Wai-Man C, Tagalakis AD. The Effect of Cryoprotectants and Storage Conditions on the Transfection Efficiency, Stability, and Safety of Lipid-Based Nanoparticles for mRNA and DNA Delivery. Adv Healthc Mater 2023;:e2203022. [PMID: 36906918 DOI: 10.1002/adhm.202203022] [Reference Citation Analysis]
3 Volpini L, Monaco F, Santarelli L, Neuzil J, Tomasetti M. Advances in RNA cancer therapeutics: New insight into exosomes as miRNA delivery. Aspects of Molecular Medicine 2023. [DOI: 10.1016/j.amolm.2023.100005] [Reference Citation Analysis]
4 Temaj G, Telkoparan-akillilar P, Nuhii N, Chichiarelli S, Saha S, Saso L. Recoding of Nonsense Mutation as a Pharmacological Strategy. Biomedicines 2023;11:659. [DOI: 10.3390/biomedicines11030659] [Reference Citation Analysis]
5 Fekete S, Doneanu C, Addepalli B, Gaye M, Nguyen J, Alden B, Birdsall R, Han D, Isaac G, Lauber M. Challenges and emerging trends in liquid chromatography-based analyses of mRNA pharmaceuticals. J Pharm Biomed Anal 2023;224:115174. [PMID: 36446261 DOI: 10.1016/j.jpba.2022.115174] [Reference Citation Analysis]
6 Vanhinsbergh C. The Role of Separation Techniques in the Analysis of mRNA Therapeutic Drug Substances and Drug Products. LCGC Eur 2023. [DOI: 10.56530/lcgc.eu.hk6689y3] [Reference Citation Analysis]
7 Lamprinou M, Sachinidis A, Stamoula E, Vavilis T, Papazisis G. COVID-19 vaccines adverse events: potential molecular mechanisms. Immunol Res 2023;:1-17. [PMID: 36607502 DOI: 10.1007/s12026-023-09357-5] [Reference Citation Analysis]
8 Vavilis T, Stamoula E, Ainatzoglou A, Sachinidis A, Lamprinou M, Dardalas I, Vizirianakis IS. mRNA in the Context of Protein Replacement Therapy. Pharmaceutics 2023;15. [PMID: 36678793 DOI: 10.3390/pharmaceutics15010166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chavda VP, Soni S, Vora LK, Soni S, Khadela A, Ajabiya J. mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines (Basel) 2022;10. [PMID: 36560560 DOI: 10.3390/vaccines10122150] [Reference Citation Analysis]
10 Nwokeoji AO, Chou T, Nwokeoji EA. Low Resource Integrated Platform for Production and Analysis of Capped mRNA. ACS Synth Biol 2023;12:329-39. [PMID: 36495278 DOI: 10.1021/acssynbio.2c00609] [Reference Citation Analysis]
11 Jiménez López E, Cuenca Jiménez F, Luna Sandoval G, Ochoa Estrella FJ, Maciel Monteón MA, Muñoz F, Limón Leyva PA. Technical Considerations for the Conformation of Specific Competences in Mechatronic Engineers in the Context of Industry 4.0 and 5.0. Processes 2022;10:1445. [DOI: 10.3390/pr10081445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, Zheng Q, Li G, Teng Y, Wu M, Song X. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Ther 2022;7:166. [PMID: 35597779 DOI: 10.1038/s41392-022-01007-w] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 33.0] [Reference Citation Analysis]
13 Borbone N, Piccialli I, Falanga AP, Piccialli V, Roviello GN, Oliviero G. Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era. IJMS 2022;23:4359. [DOI: 10.3390/ijms23084359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lee SS, Park J, Oh S, Kwack K. Downregulation of LOC441461 Promotes Cell Growth and Motility in Human Gastric Cancer. Cancers (Basel) 2022;14:1149. [PMID: 35267457 DOI: 10.3390/cancers14051149] [Reference Citation Analysis]
15 Roffo F, Ponsiglione AM, Netti PA, Torino E. coupled Hydrodynamic Flow Focusing (cHFF) to Engineer Lipid–Polymer Nanoparticles (LiPoNs) for Multimodal Imaging and Theranostic Applications. Biomedicines 2022;10:438. [DOI: 10.3390/biomedicines10020438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Rajendran AK, Amirthalingam S, Hwang NS. A brief review of mRNA therapeutics and delivery for bone tissue engineering. RSC Adv 2022;12:8889-900. [DOI: 10.1039/d2ra00713d] [Reference Citation Analysis]